Abstract
PURPOSE: Provincial drug programs are increasingly listing pharmaceutical products with restrictions. This may be to ensure appropriate use of a drug or serve as a cost containment strategy to control the provincial formulary budget. To determine if physicians treat asthma patients who are beneficiaries of the provincial drug plan differently than patients who have private drug plan.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
